Clinical Case Studies in Long-Term Care Psychiatry Navigating Common Mental Health Challenges in Geriatric Care
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Case 26 - “I Am a Worrier”
Schizoaffective Disorder and Antipsychotics
Published online by Cambridge University Press: 31 October 2024
Book contents
- Clinical Case Studies in Long-Term Care Psychiatry
- Clinical Case Studies in Long-Term Care Psychiatry
- Copyright page
- Contents
- Preface
- Section 1 Neurocognitive Disorders
- Case 2 “I Think I Hit My Head”
- Case 3 “It’s like She’s a Different Person”
- Case 4 “I Am Tired All the Time”
- Case 5 “I Am Okay”
- Case 6 “Leave Me Alone”
- Case 7 “I Am Fine”
- Case 8 “Those Children Are Cute”
- Case 9 “Those Terrible Men Have Left”
- Case 10 “I Saw the Heavenly Gates”
- Case 11 “Leave Me Alone”
- Section 2 Mood Disorders
- Case 13 “My Mom Looks Like a Zombie!”
- Case 14 “My Soul Is in England”
- Case 15 “I Feel Terrible”
- Case 16 “I Don’t Care”
- Case 17 “I Feel Very Lonely”
- Case 18 “I Don’t Feel Right”
- Case 19 “I Am Feeling Great”
- Case 20 “I Am Staying Here Illegally”
- Section 3 Psychotic Disorders
- Case 22 “He Just Won’t Get Up”
- Case 23 “My Body Is Being Taken over by a Fungus!”
- Case 24 “This Is Humiliating”
- Case 25 “I Want to Go Home”
- Case 26 “I Am a Worrier”
- Case 27 “Get out of My House”
- Section 4 Anxiety and Related Disorders
- Case 29 “My Vision Has Been Worsening in the Last Two Weeks”
- Case 30 “I Am Not Addicted to Valium”
- Case 31 “Of Course, I Worry about Him”
- Case 32 “Bombs Are Falling! Run, Run!”
- Section 5 Substance Abuse Disorders
- Section 6 Personality Disorders
- Case 35 “I Cannot Wait to Get out of This Miserable Place”
- Section 7 Miscellaneous Neuropsychiatric Disorders Affecting Patients in Long-Term Care
- Case 37 “Everyone Is Just So Good to Me!”
- Case 38 “Why Do They Say I Have Dementia?”
- Case 39 “I Hate That Guy … I Can’t Get Any Sleep!”
- Case 40 “Just One Kiss”
- Case 41 “I Don’t Feel Well”
- Case 42 “I Like Food”
- Case 43 “I Like the Way She Laughs”
- Case 44 “This Is So Hard”
- Index
- References
Summary
Schizoaffective disorder is a psychiatric disorder in which patients demonstrate a combination of symptoms associated with schizophrenia and a mood disorder such as bipolar disorder or depression. The symptoms of schizophrenia and mood disorder occur concomitantly for a substantial portion of the illness duration. If a resident has been stable on a psychiatric drug regimen, it is advisable to avoid any major change because obtaining a similar good therapeutic response from a different drug regimen is not predictable or assured. All antipsychotics have the potential to cause weight gain and increase the risk of obesity and related hyperlipidemia and diabetes. Atypical antipsychotics can be thought of as being high, medium, and low risk for these complications. Antipsychotics thought to be low risk for metabolic syndrome include cariprazine, lurasidone, lumateperone, ziprasidone, pimavanserin, aripiprazole, and brexpiprazole.
- Type
- Chapter
- Information
- Clinical Case Studies in Long-Term Care PsychiatryNavigating Common Mental Health Challenges in Geriatric Care, pp. 126 - 129Publisher: Cambridge University PressPrint publication year: 2024
References
References
Szmulewicz, A. G., Angriman, F., Pedroso, F. E., Vazquez, C., & Martino, D. J. (2017). Long-term antipsychotic use and major cardiovascular events: A retrospective cohort study. The Journal of Clinical Psychiatry, 78 (8), 1161.CrossRefGoogle ScholarPubMed
Stahl, S. M. (2021). Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. (Cambridge University Press.) Ebook. Kindle Edition. p. 212.CrossRefGoogle Scholar
Further Reading
Bernardo, M., Rico-Villademoros, F., García-Rizo, C., Rojo, R., & Gómez-Huelgas, R. (2021). Real-world data on the adverse metabolic effects of second-generation antipsychotics and their potential determinants in adult patients: A systematic review of population-based studies. Advances in Therapy, 38 (5), 2491–2512. www.ncbi.nlm.nih.gov/pmc/articles/PMC8107077/CrossRefGoogle ScholarPubMed
Carli, M., Kolachalam, S., Longoni, B., Pintaudi, A., Baldini, M., Aringhieri, S., & Scarselli, M. (2021). Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences. Pharmaceuticals, 14 (3), 238.CrossRefGoogle ScholarPubMed
DeJongh, B. M. (2021). Clinical pearls for the monitoring and treatment of antipsychotic induced metabolic syndrome. Mental Health Clinician, 11 (6), 311–319.CrossRefGoogle ScholarPubMed
Friedrich, M. E., Winkler, D., Konstantinidis, A., Huf, W., Engel, R., Toto, S., Grohmann, R., & Kasper, S. (2020). Cardiovascular adverse reactions during antipsychotic treatment: Results of AMSP, a drug surveillance program between 1993 and 2013. The International Journal of Neuropsychopharmacology, 23 (2), 67–75. https://doi.org/10.1093/ijnp/pyz046CrossRefGoogle ScholarPubMed
Hammoudeh, S., Al Lawati, H., Ghuloum, S., Iram, H., Yehya, A., Becetti, I., & Al-Amin, H. (2020). Risk factors of metabolic syndrome among patients receiving antipsychotics: A retrospective study. Community Mental Health Journal, 56, 760–770.CrossRefGoogle ScholarPubMed
Sneller, M. H., De Boer, N., Everaars, S., Schuurmans, M., Guloksuz, S., Cahn, W., & Luykx, J. J. (2021). Clinical, biochemical and genetic variables associated with metabolic syndrome in patients with schizophrenia spectrum disorders using second-generation antipsychotics: a systematic review. Frontiers in Psychiatry, 12, 625935.CrossRefGoogle ScholarPubMed
Ventriglio, A., Baldessarini, R. J., Vitrani, G., Bonfitto, I., Cecere, A. C., Rinaldi, A., & Bellomo, A. (2019). Metabolic syndrome in psychotic disorder patients treated with oral and long-acting injected antipsychotics. Frontiers in Psychiatry, 9, 744.CrossRefGoogle ScholarPubMed